Active, not recruitingPhase 3NCT06942988

Efficacy of Intracavernous Platelet-rich Plasma Injection in the Treatment of Erectile Dysfunction

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Intervention
intracavernous platelet rich plasma therapy(biological)
Enrollment
34 target
Eligibility
40-70 years · MALE
Timeline
20232025

Study locations (1)

Collaborators

t-biyoteknoloji labaratuvar estetik medikal kozmetik san. ve tic. ltd. şti.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06942988 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials